Jump to content

  • Buscar
Language selector
  • My Quirónsalud
What can I do with Mi Quirónsalud?
What can I do with Mi Quirónsalud?
  • View the results of your diagnostic and clinical tests
  • Manage your appointments and receive notifications
  • Communicate with your doctor
  • Receive health-related advice
  • Add external documents and reports

imagen icono documento

Quick access to Quirónsalud laboratory test results and other documents

Quick access to Quirónsalud laboratory test results and other documents

To access test results, you must previously have been notified via email or test message.

imagen icono documento

Quick access to Quirónsalud laboratory test results and other documents

Quick access to Quirónsalud laboratory test results and other documents

To access test results, you must previously have been notified via email or test message.

Complete field

/ /

Complete field

Incorrect date entered

Complete field

I hereby declare that I hold custody rights over the minor whose medical records I am accessing at this time. Should I lose my rights of custody or guardianship for any reason, I endeavor to inform the hospital to this effect without delay.

You must accept the conditions

  • Home
  •   |   Virtual press room
  •   |   Press releases
  •   |   Long-Term Nevirapine Safe and Effective in Treating HIV, With No Deterioration of Lipid Profile: Presented at ECCMID

Long-Term Nevirapine Safe and Effective in Treating HIV, With No Deterioration of Lipid Profile: Presented at ECCMID

Long-term nevirapine (NVP)-based highly active antiretroviral therapy (HAART) is safe and effective for patients infected with HIV, with no deterioration seen in subjects lipid profiles, according to a retrospective study presented at the 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).

19 de abril de 2010
The combination of protease inhibitors (PIs) with HAART -- a mainstay of treatment for patients with HIV infection -- is commonly associated with hypercholesterolaemia and hypertriglyceridaemia. The use of NVP, however, has provided a therapy with limited adverse effects on patients' lipid profiles, noted principal investigator Cristina Hidalgo, MD, Infectious Diseases Division, Fundación Jiménez Diaz, Madrid, Spain, speaking here on April 11.
Fuente: pslgroup.com

Available files

© 2023 Quirónsalud - All rights reserved

Employees

Información sobre la restructuración societaria en la que Grupo Hospitalario Quirón, S.A. actúa como sociedad absorbida y Quirón Hospitales, S.L.U. como absorbente (artículo 39 Ley Modificaciones Estructurales)